USNA.NYSEUsana Health Sciences INC

Form 4: USANA CEO Kevin Guest Reports Routine Stock Transactions

Sentiment:

Insider Transaction Report

📋All filings for Usana Health Sciences INC
🔒Login to Follow

USANA Health Sciences CEO Kevin Guest reported the vesting of restricted stock units and subsequent sale of shares for tax purposes.

Summary

  • Kevin Guest, CEO & Executive Chairman of the Board for USANA Health Sciences Inc. (USNA), reported transactions on February 27, 2026.
  • 7,856 Restricted Stock Units (RSUs) vested, leading to the acquisition of 7,856 shares of common stock.
  • Concurrently, 3,328 shares of common stock were disposed of at a price of $21.52 per share, likely to cover tax obligations related to the RSU vesting.
  • Following these transactions, Kevin Guest directly owns 45,381 shares of common stock and 127,206 Restricted Stock Units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine insider transaction related to equity compensation, which typically has a neutral impact on market sentiment.

Positives

  • The vesting of Restricted Stock Units indicates the execution of long-term incentive plans for executive compensation.

Negatives

  • A portion of the vested shares (3,328 shares) was sold, reducing direct common stock ownership, although this is a common practice for tax withholding.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to the vesting of equity awards and subsequent tax-related sales, are routine events for executives and generally do not signal a change in the company's strategic direction or financial health.

Stakeholder Impact

  • The transactions are part of executive compensation and are unlikely to have a significant direct impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

DateDescription
02/27/2025Anniversary date for 25% vesting of Restricted Stock Units.
02/27/2026Date of reported transactions, including RSU vesting and stock disposition.
03/03/2026Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

The reported transactions are standard for executive equity compensation, involving the vesting of restricted stock units and the sale of a portion of shares to cover tax obligations. This type of insider activity does not typically signal a change in the company's fundamental outlook or warrant a shift in investment recommendation.

Keywords

USANA Health Sciences, USNA, Kevin Guest, Form 4, insider trading, stock transactions, RSU vesting, common stock, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.